Allelic variants of human cytochrome P450 2C9: Baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and 1359L mutant forms

Archives of Biochemistry and Biophysics

Volumn 333, Issue 2, 1996, Pages 447-458

  Haining, Robert L ^a   Hunter, Ann P ^a   Veronese, Maurice E ^b   Trager, William F ^a   Rettie, Allan E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

baculovirus; CYP2C9; cytochrome P450; expression; stereoselectivity; warfarin

Indexed keywords

CYTOCHROME P450; WARFARIN;

AEROBIC METABOLISM; ALLELE; ARTICLE; DRUG METABOLISM; ENZYME KINETICS; ENZYME PURIFICATION; ENZYME SPECIFICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; STEREOCHEMISTRY;

UNIDENTIFIED BACULOVIRUS;

EID: 0030587544     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.1996.0414     Document Type: Article

References (50)

1. 1. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C., and Nebert, D. W. (1996) Pharmacogenetics 6, 1-42.
2. 2. Gonzalez, F. J. (1990) Pharmacol. Ther. 45, 1-38.
3. 3. Gonzalez, F. J., and Nebert, D. W. (1990) Trends Genet. 6, 182-186.
4. 4. Wrighton, S. A., and Stevens, J. C. (1992) Crit. Rev. Toxicol. 22, 1-21.
5. 5. Gray, I. C., Nobile, C., Muresu, R., Ford, S., and Spurr, N. K. (1995) Genomics 28, 328-332.
6. 6. Goldstein, J. A., and de Morais, S. M. F. (1994) Pharmacogenetics 4, 285-299.
7. 7. Veronese, M. E., Mackenzie, P. I., Doecke, C. J., McManus, M. E., Miners, J. O., and Birkett, D. J. (1991) Biochem. Biophys. Res. Commun. 175, 1112-1118.
8. 8. Veronese, M. E., Doecke, C. J., Mackenzie, P. I., McManus, M. E., Miners, J. O., Rees, D. L. P., Gasser, R., Meyer, U. A., and Birkett, D. J. (1993) Biochem. J. 289, 533-538.
9. 9. Brian, W. R., Srivastava, P. K., Umbenhauer, D. R., Lloyd, R. S., and Guengerich, F. P. (1989) Biochemistry 28, 4993-4999.
10. 10. Garcia, M. P. L., Dansette, P. M., Valadon, P., Amar, C., Beaune, P., Guengerich, F. P., and Mansuy, D. (1993) Eur. J. Biochem. 213, 223-232.
11. 11. Zhao, J., Leemann, T., and Bayer, P. (1992) Life Sci. 51, 575-581.
12. 12. Leemann, T. D., Transon, C., Bonnabry, P., and Dayer, P. (1993) Drugs Exp. Clin. Res. 19, 189-195.
13. 13. Tracy, T. S., Rosenbluth, B. W., Wrighton, S. A., Gonzalez, F. J., and Korzekwa, K. R. (1995) Biochem. Pharmacol. 49, 1269-1275.
14. 14. Rettie, A. E., Korzekwa, K. R., Kunze, K. L., Lawrence, R. F., Eddy, A. C., Aoyama, T., Gelboin, H. V., Gonzalez, F. J., and Trager, W. F. (1992) Chem. Res. Toxicol. 5, 54-59.
15. 15. Lewis, R. J., Trager, W. F., Chan, K. K., Breckenridge, A., Orme. M., Rowland, M., and Schary, W. (1974) J. Clin. Invest. 53, 1607-1617.
16. 16. Toon, S., Low, L. K., Gibaldi, M., Trager, W. F., O'Reilly, R. A., Motley, C. H., and Goulart, K. A. (1986) Clin. Pharmacol. Ther. 39, 15-24.
17. 17. Kimura, S., Pastewka, J., Gelboin, H. V., and Gonzalez, F. J. (1987) Nucleic Acids Res. 15, 10053-10054.
18. 18. Yasumori, T. S., Kawano, K., Nagata, M., Shimada, Y., Yamazoe, Y., and Kato, R. (1987) J. Biochem. 102, 1075-1082.
19. 19. Meehan, R. R., Gosden, J. R., Rout, D., Hastle, N. D., Friedberg, T., Adesnik, M., Buckland, R., van Heyningen, V., Fletcher, J., Spurr, N. K., Sweeney, J., and Wolf, C. R. (1988) Am. J. Hum. Genet. 42, 26-37.
20. 20. Ged, C., Umbenhauer, D. R., Beilew, T. M., Bork, R. W., Srivastava, P., Shinriki, N., Lloyd, R. S., and Guengerich, F. P. (1988) Biochemistry 27, 6929-6940.
21. 21. Romkes, M., Faletto, M. B., Blaisdell, J. A., Raucy, J. L., and Goldstein, J. A. (1991) Biochemistry 30, 3247-3255.
22. 22. Wang, S-L., Huang, J-d., Lai, M-D., and Tsai, J-J. (1995) Pharmacogenetics 5, 37-42.
23. 23. Sullivan, T. H., Birkett, D. J., Bell, D. A., Ghanayem, B. I., Shenfield, G. M., and Goldstein, J. A. (1995) in ISSX Proceedings of the 4th International Meeting, Seattle, Washington, Vol. 8, p. 106, International Society for the Study of Xenobiotics, Bethesda, MD.
24. 24. Furuya, H., Fernandez-Salguero, P., Gregory, P., Taber, H., Steward, A., Gonzalez, F. J., and Idle, J. R. (1995) Pharmacogenetics 5, 389-392.
25. 25. Gotoh, O. (1992) J. Biol. Chem. 267, 83-90.
26. 26. Rettie, A. E., Bogucki, B. D., Lim, I., and Meier, G. P. (1990) Mol. Pharmacol. 37, 643-651.
27. 27. Fisher, M. B., Lawton, M. P., Atta-Asafo-Adjei, E., Philpot, R. M., and Rettie, A. E. (1995) Drug Metab. Dispos. 23, 1431-1433.
28. 28. Rettie, A. E., Eddy, A. C., Heimark, L. D., Gibaldi, M., and Trager, W. F. (1989) Drug Metab. Dispos. 17, 265-270.
29. 29. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1989) in Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
30. 30. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci USA 74, 5463-5467.
31. 31. Estabrook, R. W., Peterson, J., Baron, J., and Hildebrandt, A. (1972) Methods Pharmacol. 2, 303-350.
32. 32. Jones, J. P., Rettie, A. E., and Trager, W. F. (1990) J. Med. Chem. 33, 1242-1246.
33. 33. Rettie, A. E., Wienkers, L. C., Gonzalez, F. J., Trager, W. F., and Korzekwa, K. R. (1994) Pharmacogenetics 4, 39-42.
34. 34. Kaminsky, L. S., de Morals, S. M. F., Faletto, M. B., Dunbar, D., and Goldstein, J. A. (1993) Mol. Pharmacol. 43, 234-239.
35. 35. Asseffa, A., Smith, S. J., Nagata, K., Gillette, J., Gelboin, H. V., and Gonzalez, F. J. (1989) Arch. Biochem. Biophys. 274, 481-490.
36. 36. Gonzalez, F. J., and Korzekwa, K. R.. (1995) Annu. Rev. Pharmacol. Toxicol. 35, 369-390.
37. 37. Grogan, J., Shou, M., Andrusiak, E. A., Tamura, S., Buters, J. M., Gonzalez, F. J., and Korzekwa, K. R. (1995) Biochem. Pharmacol. 50, 1509-1515.
38. 38. Rettie, A. E., Meier, G. P., and Sadeque, A. J. M. (1995) Chem.-Biol. Interact. 96, 3-15.
39. 39. Buters, J. T., Korzekwa, K. R., Kunze, K. L., Omata, Y., Hardwick, J. P., and Gonzalez, F. J. (1994) Drug Metab. Dispos. 22, 688-692.
40. 40. Buters, J. T. M., Shou, M., Hardwick, J. P., Korzekwa, K. R., and Gonzalez, F. J. (1995) Drug Metab. Dispos. 23, 695-701.
41. 41. Zeldin, D. C., DuBois, R. N., Falck, J. R., and Capdevila, J. G. (1995) Arch. Biochem. Biophys. 322, 76-86.
42. 42. Goldstein, J. A., Faletto, M. B., Romkes-Sparks, M., Sullivan, T., Raucy, J. L., Kitareewan, S., Lasker, J. M., and Ghanayem, B. (1994) Biochemistry 33, 1743-1752.
43. 43. Spielberg, S., McCrea, J., Cribb, A., Rushmore, T., Waldman, S., Bjornsson, T., Lo, M-W., and Goldberg, M. (1996) in Abstracts of the 97th Meeting of the American Society for Clinical Pharmacology and Therapeutics, Lake Buena Vista, FL, p. 215.
44. 44. Haseman, C. A., Kurumbail, R. G., Bodupalli, S. S., Peterson, J. A., and Diesenhofer, J. (1995) Structure 3, 41-62.
45. 45. Korzekwa, K. R., and Jones, J. P. (1993) Pharmacogenetics 3, 1-8.
46. 46. Richardson, T. H., and Johnson, E. F. (1994) J. Biol. Chem. 269, 23937-23943.
47. 47. Iwasaki, M., Darden, T. A., Pedersen, L. G., and Negishi, M. (1995) Biochemistry 34, 5054-5059.
48. 48. Halpert, J. R., and He, Y. A. (1993) J. Biol. Chem. 268, 4453-4457.
49. 49. Luo, Z., He, Y. A., and Halpert, J. R. (1994) Arch. Biochem. Biophys. 309, 52-57.
50. 50. Jones, J. P., He, M., Trager, W. F., and Rettie, A. E. (1996) Drug Metab. Dispos. 24, 1-6.